2,404 results on '"Rosenfeld, M"'
Search Results
2. The Effect of Hypochlorite-Induced Fibrinogen Oxidation on the Protein Structure, Fibrin Self-Assembly, and Fibrinolysis
3. Development of a Diagnostic Approach Based on the Detection of Post-Translation Modifications of Fibrinogen Associated with Oxidative Stress by the Method of High Efficiency Liquid Chromatography
4. EPS4.07 Validation of home spirometry as a CF clinical trial endpoint: results of the OUTREACH study
5. P319 The impact of a whole foods dietary intervention on gastrointestinal (GI) symptoms, inflammation, and fecal microbiota in paediatric patients with cystic fibrosis: a pilot study
6. P236 Investigating the impact of elexacaftor/tezacaftor/ivacaftor therapy on longitudinal oropharyngeal microbiome dynamics in children with cystic fibrosis
7. Functional Role of Methionine Oxidation in Proteins: Arguments for and against
8. Effect of Hypochlorite- and Hydrogen Peroxide-Induced Oxidation of Fibrinogen on its Thermal Denaturation
9. Peroxide-Induced Damage to Plasminogen Molecules
10. Effect of Hypochlorite- and Peroxide-Induced Oxidation of Fibrinogen on the Fibrin Structure
11. Pediatric lung function testing during a pandemic: An international perspective
12. Advancing Equity in Mobile Health Tools for Asthma: A Focus Group Study of Hispanic and Latinx Community Perspectives
13. Hypochlorite-Induced Disturbance in the Secondary Structure of the Coagulation Factor XIII
14. The Nature of Resistance of the Coagulation Factor XIII Structure to Hypochlorite-Induced Oxidation
15. Oxidative Modification of Coagulation Factor XIII: Structural and Functional Aspects
16. The Structural–Functional Damage of Fibrinogen Oxidized by Hydrogen Peroxide
17. Multiscale Fluctuation Dynamics of Polymer Gels
18. Brain tumor epidemiology - A hub within multidisciplinary neuro-oncology. report on the 15th brain tumor epidemiology consortium (BTEC) annual meeting, Vienna, 2014
19. Initial development and pilot testing of observer-reported outcomes (ObsROs) for children with cystic fibrosis ages 0–11 years
20. Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis
21. 123 Home spirometry as a cystic fibrosis clinical trial endpoint: results of the OUTREACH Study.
22. Hypochlorite-Induced Damage of Plasminogen Molecules: Structural-Functional Disturbance
23. Peroxide-Induced Oxidative Modification of Hemoglobin
24. 607 Characteristics of individuals in the United States ineligible for ivacaftor and elexacaftor-tezacaftor-ivacaftor
25. 124 Is home spirometry accurate? Comparison between home and office spirometry in the PROMISE study
26. 540 Impact of elexacaftor-tezacaftor-ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function, and fat malabsorption: Report of PROMISE PEDS GI
27. 141 Factors associated with significantly corrected sweat chloride in people with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor—results from the PROMISE and RECOVER studies
28. 112 The lung clearance index to inform clinical decision-making in early cystic fibrosis lung disease: findings from a prospective study
29. 513 Effect of CFTR modulator treatment on digestive disorders: analysis of ivacaftor licensing in the U.K. and U.S. cystic fibrosis registries
30. 118 Research coordination perceptions of a coached home spirometry protocol: ongoing experiences with the OUTREACH study
31. Hypochlorite-Induced Oxidative Modification of Fibrinogen
32. EPS5.02 Faecal microbiota changes in patients with cystic fibrosis with 6 months of elexacaftor/tezacaftor/ivacaftor: preliminary findings from the PROMISE study
33. Asthma Characteristics and Allergic Sensitization Among Adolescents With HIV and HIV-uninfected Adolescents in Nairobi, Kenya
34. Inclusivity of the North American Primary Ciliary Dyskinesia (PCD) Foundation Clinical Registry
35. Long-term Exposure to Air Pollution and Lung Function in Cystic Fibrosis
36. Airway Disease Progression on Chest Computed Tomography in Children With Primary Ciliary Dyskinesia
37. Evaluating a Mobile Health Tool to Guide Management of Acute Pediatric Respiratory Illnesses: A Pilot Feasibility Study in 2 Ugandan Primary Care Health Centers
38. Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis
39. The Transcription Factor KLF2 Restrains CD4+ T Follicular Helper Cell Differentiation
40. Study of Human Fibrinogen Oxidative Modification using Differential Scanning Calorimetry
41. Oxidation-induced modification of the fibrinogen polypeptide chains
42. Modification of human serum albumin under induced oxidation
43. Modification of the catalytic subunit of plasma fibrin-stabilizing factor under induced oxidation
44. Prenatal β-catenin/Brn2/Tbr2 transcriptional cascade regulates adult social and stereotypic behaviors
45. The oxidative modification of cellular fibrin-stabilizing factor
46. 548 Locus near ICOS is genetic modifier for risk of Mycobacterium avium complex airway infection in persons with cystic fibrosis
47. 213 Composition of fecal microbiota and bile acid abundances with 1 month of elexacaftor/tezacaftor/ivacaftor in pediatric patients with cystic fibrosis: Preliminary findings from PROMISE Pediatrics Study
48. 224 Elexacaftor/tezacaftor/ivacaftor alters gastrointestinal symptoms and inflammation: Report of PROMISE Pediatric Gastrointestinal Study
49. 119 Pulmonary exacerbation antibiotic treatment for children with cystic fibrosis and polymicrobial infection
50. 41 Association between Pseudomonas aeruginosa infection stage and lung function trajectory in children with cystic fibrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.